共 329 条
- [71] Smogorzewski M(2022)Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients J Nephrol 35 371-1498
- [72] Steiger S(2022)The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland J Am Soc Nephrol 33 49-167
- [73] Rossaint J(2022)Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study Clin Kidney J 15 1037-1410
- [74] Zarbock A(2022)SARS-CoV-2 vaccine antibody response and breakthrough infection in patients receiving dialysis Ann Intern Med 175 1496-5088
- [75] Anders HJ(2022)Real-world effectiveness and immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in patients on hemodialysis J Am Soc Nephrol 33 360-2474
- [76] Li J(2021)Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis Clin J Am Soc Nephrol 16 1709-1734
- [77] Li SX(2021)Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients Kidney Int 99 821-1392
- [78] Zhao LF(2021)Humoral response to SARS-CoV-2-vaccination with BNT162b2 (Pfizer-BioNTech) in patients on hemodialysis Vaccines (Basel). 9 1491-55
- [79] Kong DL(2021)Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls Nephrol Dial Transpl 36 13-944
- [80] Guo ZY(2022)The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant Transplantation 106 163-3961.e11